Company Filing History:
Years Active: 2011
Title: H S Manjunath: Innovator in Insulin Conjugate Technology
Introduction
H S Manjunath is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of biotechnology, particularly in the development of insulin conjugates. His innovative work has the potential to enhance diabetes treatment options.
Latest Patents
H S Manjunath holds a patent for a process related to the preparation of an insulin conjugate known as IN-105. This invention claims a method for creating an insulin-oligomer conjugate, which involves cloning and expressing a precursor with a specific formula. The process includes conjugating the biosynthetic precursor with an activated oligomer, followed by treatment with protease to purify the active insulin-oligomer conjugate.
Career Highlights
Manjunath is associated with Biocon Limited, a leading biopharmaceutical company in India. His work at Biocon has allowed him to focus on innovative solutions in the field of insulin therapy. His contributions have been instrumental in advancing the company's research and development efforts.
Collaborations
Some of H S Manjunath's coworkers include Nitesh Dave and Partha Hazra. Their collaboration has fostered a productive environment for innovation and research within Biocon Limited.
Conclusion
H S Manjunath's work in the development of insulin conjugates represents a significant advancement in diabetes treatment. His innovative approach and dedication to research continue to impact the field positively.